{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T02:12:47Z","timestamp":1648606367558},"reference-count":33,"publisher":"Elsevier BV","issue":"7-8","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.gyobfe.2010.05.003","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T04:24:07Z","timestamp":1277785447000},"page":"447-454","source":"Crossref","is-referenced-by-count":1,"title":["Valeur pr\u00e9dictive du Doppler ut\u00e9rin et suivi des patientes avec syndrome des anti-phospholipides \u00e0 haut risque obst\u00e9trical\u00a0: l\u2019exp\u00e9rience rouennaise"],"prefix":"10.1016","volume":"38","author":[{"given":"J.","family":"Seror","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Verspyck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-Y.","family":"Borg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Berkane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Marpeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gyobfe.2010.05.003_bib1","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/S0029-7844(01)01251-0","article-title":"The clinical significance of absence of end-diastolic velocities of the umbilical artery detected in the severely preterm fetus","volume":"97","author":"Chavez","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0002-9378(98)70154-1","article-title":"Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome","volume":"179","author":"Mires","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib3","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0002-9378(92)91683-2","article-title":"Interrelationship and clinical significance of increased resistance in the uterine arteries in patients with hypertension or pre-eclampsia or both","volume":"166","author":"Kofinas","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/rheumatology\/kei159","article-title":"The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and\/or the antiphospholipid syndrome","volume":"45","author":"Le Thi Huong","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1056\/NEJM198507183130304","article-title":"Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus","volume":"313","author":"Lockshin","year":"1985","journal-title":"N Eng J Med"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib8","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1056\/NEJM198511213132104","article-title":"Obstetric complications associated with the lupus anticoagulant","volume":"313","author":"Branch","year":"1985","journal-title":"N Eng J Med"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib9","first-page":"131","article-title":"A study of sixty pregnancies in patients with the antiphospholipid syndrome","volume":"14","author":"Lima","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib10","first-page":"614","article-title":"Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience","volume":"80","author":"Branch","year":"1992","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib11","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib13","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0897.1996.tb00501.x","article-title":"A clinical trial for the treatment of antiphospholipid antibody-associated recurrent pregnancy loss with lower dose heparin and aspirin","volume":"35","author":"Kutteh","year":"1996","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib14","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(83)92865-9","article-title":"Unsuspected pregnancy loss in healthy women","volume":"1","author":"Whittaker","year":"1983","journal-title":"Lancet"},{"issue":"75","key":"10.1016\/j.gyobfe.2010.05.003_bib15","article-title":"Survival probability of human conceptions from fertilization to term","volume":"35","author":"Boklage","year":"1990","journal-title":"Int Jour Fertil"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib16","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1136\/ard.50.8.553","article-title":"Prevalence of antiphospholipid antibodies in patients with fetal loss","volume":"50","author":"Out","year":"1991","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib17","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0002-9378(11)91407-0","article-title":"Etiologic factors of recurrent abortion and subsequent reproductive performance of couples: have we made any progress in the past 10\u00a0years?","volume":"167","author":"Plouffe","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib18","first-page":"1","article-title":"Spontaneous abortion risks in man: data from reproductive histories collected in a medical genetics unit","volume":"16","author":"Warburton","year":"1964","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/ajmg.1320160415","article-title":"Subsequent reproductive outcome in couples with repeated pregnancy loss","volume":"16","author":"FitzSimmons","year":"1983","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0301-2115(95)02189-E","article-title":"Uterine Doppler wave form and the prediction of the recurrence of pre-eclampsia and intra-uterine growth retardation in patients treated with low-dose aspirin","volume":"62","author":"Haddad","year":"1995","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib21","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000077971","article-title":"Prospective evaluation of uterine artery flow velocity waveforms at 12\u201314\u00a0and 22\u201324\u00a0weeks of gestation in relation to pregnancy outcome and birth weight","volume":"19","author":"Carbillon","year":"2004","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib22","first-page":"970","article-title":"Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome","volume":"82","author":"Caruso","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000263700","article-title":"Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome","volume":"7","author":"Benifla","year":"1992","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0029-7844(01)01460-0","article-title":"Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome","volume":"98","author":"Venkat-Raman","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1196\/annals.1422.056","article-title":"Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid syndrome: a review","volume":"1108","author":"De Carolis","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejogrb.2003.09.040","article-title":"Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy","volume":"114","author":"Bats","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib27","first-page":"883","article-title":"Recurrent stillbirth. Significance and characteristics","volume":"38","author":"Samueloff","year":"1993","journal-title":"J Reprod Med"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib28","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0002-9378(92)91596-3","article-title":"Repeated fetal losses associated with antiphospholipid antibodies: a collaborative randomized trial comparing prednisone with low-dose heparin treatment","volume":"166","author":"Cowchock","year":"1992","journal-title":"Am J Obstetrics Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1471-0528.1999.tb08208.x","article-title":"Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin","volume":"106","author":"Backos","year":"1999","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.10957","article-title":"Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies","volume":"48","author":"Triolo","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib31","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.fertnstert.2004.11.002","article-title":"Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","volume":"83","author":"Noble","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0029-7844(02)02165-8","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.gyobfe.2010.05.003_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.revmed.2008.05.016","article-title":"Pregnancy and systemic lupus erythematosus","volume":"29","author":"L\u00ea Thi Huong","year":"2008","journal-title":"Rev Med Interne."}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958910001608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297958910001608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,9]],"date-time":"2018-12-09T23:26:54Z","timestamp":1544398014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297958910001608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":33,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1297958910001608"],"URL":"https:\/\/doi.org\/10.1016\/j.gyobfe.2010.05.003","relation":{},"ISSN":["1297-9589"],"issn-type":[{"value":"1297-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}